UMC has an international Board; WHO and the Swedish Government each appoints three members.
The operations of the UMC as a WHO Collaborating Centre are governed by an agreement between WHO Headquarters and the Swedish Government. The Centre has an international Board; WHO and the Swedish Government each appoints three members.
From 2010 the Chairman of the Board has been Dr Anders Milton, who has held senior positions in many Swedish health-related organisations.
The other members appointed by the Swedish Government are:
Dr Thomas Bradley, Clinical Pharmacologist, Karolinska University Hospital
Dr Filippa Nyberg, Executive Director, Swedish Society of Medicine
Professor Johanna Adami, Principal, Sophiahemmet University
Ms Inger Andersson, various appointments, including former acting Director General at the Medical Products Agency in Sweden
Associate Professor Anders Grahnén, President, Grahnen Consulting AB
WHO has appointed:
Ms Emer Cooke, Head, Regulation of Medicines and other Health Technologies, Essential Medicines and Health Products, World Health Organization
Ms Sophie Sommerer, Director, Marketed Biologicals, Biotechnology and Natural Health Products Bureau, Canada
Dr Fred Moin Siyoi, CEO, Pharmacy and Poisons Board, Kenya
Dr Shanthi Pal, Group Lead, Medicines Safety, Safety & Vigilance, World Health Organization
Dr Rika Wakao, Review Director, Office of Regulatory Science, Office of Safety II, Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Mr Mick Foy, Group Manager, MHRA , Vigilance and Risk Management of Medicines